Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation for Long-term Use in Pediatrics

NCT01232322 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01232322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01232322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation for Long-term Use in Pediatrics
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2011
Enrollment
633 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma